Avalon Global Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,200
Closed -$5.69M 44
2024
Q2
$5.69M Buy
50,200
+10,200
+26% +$1.29M 1.29% 31
2024
Q1
$5.55M Hold
40,000
0.8% 33
2023
Q4
$4.96M Buy
+40,000
New +$4.09M 1.74% 23

Other funds holding DXCM

Avalon Global Asset Management's DXCM Position: Q3 2024 in Review

Avalon Global Asset Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 50,200 shares — an estimated $5.69M sold.

Avalon Global Asset Management first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $5.69M in Q2 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Avalon Global Asset Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Avalon Global Asset Management sold 50,200 DexCom shares in Q3 2024, an estimated $5.69M.
  • Avalon Global Asset Management first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
  • Avalon Global Asset Management's DexCom position peaked at $5.69M in Q2 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Avalon Global Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.